… . Ongoing clinical trials for novel medications also support the … the Diet Pills include Cheplapharm, Arena Pharmaceuticals GmbH, GlaxoSmithKline Pharmaceuticals Ltd., … Some of the FDA approved medications include orlistat, lorcaserin, phentermine-topiramate, …

… FDA granted an outrageously expensive approval poised to double Medicare pharmaceutical spending … trials and has significant safety risks.  The FDA also then approved Lorcaserin … and biotechnology at the Yale University School of Medicine and an FDA Medical …

… medication about one year before the FDA … Cancer Risk Belviq (lorcaserin) was first … pills. Before Eisai and Arena Pharmaceuticals began to aggressively market the drug … treatment. Tags: Belviq, Cancer, Colorectal Cancer, Drug Recall, Weight Loss Pill

… , Inc. and Arena Pharmaceuticals concealed information about the … be caused by Belviq (lorcaserin). Eisai and Arena introduced … Belviq, the drug makers aggressively marketed the treatment as safe and … an FDA advisory panel decided to approve the medication in …

… lorcaserin) was introduced in 2012, as the first new diet drug … associated with other weight loss medications. However, following a large … the diet drug makers Eisai Inc. and Arena Pharmaceuticals indicate that … the CAMEILLIA-TIMI 61 Trial was published by the …

… on the FDA to add the active pharmaceutical ingredient in … lorcaserin to the withdrawn drug list, and for the FDA … to adequately research the medication or provide adequate warnings … treatment. Tags: Belviq, Breast Cancer, Cancer, Drug Recall, Weight Loss Pill

… lorcaserin) was introduced in 2012, as the first new diet drug … associated with other weight loss medications. However, following a … consolidation is common in complex pharmaceutical litigation, where a large … the CAMEILLIA-TIMI 61 Trial was published by the …

… Arena Pharmaceuticals, Inc., failed to properly test the drug before … marketing the controversial weight-loss treatment. Belviq (lorcaserin) … CAMEILLIA-TIMI 61 Trial was published by … the medication was first approved, the FDA required the drug …

… eludes pharmaceutical companies. Lorcaserin The active ingredient in Belviq, lorcaserin, … Belviq, seek a medical professional and then … FDA reviewed a clinical trial that was a contingency for lorcaserin … consult with your doctor about the best alternative …

… Eisai, Inc. and Arena Pharmaceuticals, Inc. failed to warn … . Belviq (lorcaserin) was introduced as a weight-loss treatment in 2012 … with other medications. However, the FDA required the diet drug makers to … the CAMEILLIA-TIMI 61 Trial was published by the …